United Capital Financial Advisers LLC grew its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 284.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 314,276 shares of the pharmacy operator’s stock after acquiring an additional 232,505 shares during the period. United Capital Financial Advisers LLC’s holdings in Walgreens Boots Alliance were worth $17,181,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also made changes to their positions in the company. NEXT Financial Group Inc lifted its position in shares of Walgreens Boots Alliance by 27.8% in the second quarter. NEXT Financial Group Inc now owns 2,663 shares of the pharmacy operator’s stock worth $145,000 after buying an additional 580 shares in the last quarter. First National Bank of South Miami increased its stake in Walgreens Boots Alliance by 3.0% during the second quarter. First National Bank of South Miami now owns 10,386 shares of the pharmacy operator’s stock worth $566,000 after acquiring an additional 303 shares during the last quarter. Synovus Financial Corp increased its stake in Walgreens Boots Alliance by 3.6% during the second quarter. Synovus Financial Corp now owns 16,177 shares of the pharmacy operator’s stock worth $883,000 after acquiring an additional 555 shares during the last quarter. H D Vest Advisory Services bought a new stake in Walgreens Boots Alliance during the second quarter worth approximately $236,000. Finally, Cornerstone Advisors Inc. increased its stake in Walgreens Boots Alliance by 131.6% during the second quarter. Cornerstone Advisors Inc. now owns 894 shares of the pharmacy operator’s stock worth $49,000 after acquiring an additional 508 shares during the last quarter. Institutional investors and hedge funds own 59.80% of the company’s stock.
Shares of WBA traded up $0.43 during mid-day trading on Friday, reaching $55.99. 3,258,578 shares of the company’s stock traded hands, compared to its average volume of 4,508,029. The stock has a market cap of $52.44 billion, a P/E ratio of 9.30, a P/E/G ratio of 1.45 and a beta of 0.88. The stock’s 50-day moving average is $52.35 and its two-hundred day moving average is $55.07. Walgreens Boots Alliance Inc has a 12 month low of $49.03 and a 12 month high of $86.31. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.05. The firm had revenue of $34.59 billion for the quarter, compared to analysts’ expectations of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company’s quarterly revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.53 earnings per share. Research analysts predict that Walgreens Boots Alliance Inc will post 5.98 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th were paid a dividend of $0.458 per share. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date was Monday, August 19th. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.27%. Walgreens Boots Alliance’s dividend payout ratio is currently 30.40%.
WBA has been the topic of several analyst reports. JPMorgan Chase & Co. reduced their price objective on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research note on Friday, June 28th. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday. ValuEngine raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective on the stock. in a research note on Monday, June 10th. Finally, Cleveland Research reissued a “hold” rating on shares of Walgreens Boots Alliance in a research note on Monday, September 9th. Seven analysts have rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $63.65.
In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the company’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the transaction, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: How accurate is the Rule of 72?
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.